Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast.
Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January.
Recent highlights for the company included the launch of the Color iLet system with a color screen and brighter display. The company also launched the first-to-market integration of iLet with the Abbott FreeStyle Libre 3 Plus in the U.S. during the fourth quarter. (Read more about how Beta Bionics got to this point as explained by founder Ed Damiano earlier this month.)
Get the full story at our sister site, Drug Delivery Business News.
